Persistent Atrial Fibrillation Phenotypes and Ablation Outcomes
JACC: Clinical Electrophysiology · 2025-01 · 11 (1) · 10-18
DOI: 10.1016/j.jacep.2024.09.018 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2025-01. Verfasst von Rose Crowley und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Alfred Hospital, Melbourne, Australia; The Baker Heart and Diabetes Research Institute, Melbourne, Australia; Departmen…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Many patients with persistent atrial fibrillation (PsAF) have progressed from an initial paroxysmal phenotype; however, there are patients in whom atrial fibrillation (AF) is persistent at diagnosis. Relatively little is known about this subgroup, but prior observational studies have suggested these patients have worse outcomes with ablation. OBJECTIVES: This study sought to: 1) assess demographic and electrophysiologic characteristics of patients with PsAF at first diagnosis compared with those with who have progressed from paroxysmal atrial fibrillation (PAF); and 2) assess the impact of pattern of AF at diagnosis on recurrence post ablation. METHODS: CAPLA (Catheter Ablation for persistent atrial fibrillation: A Multicentre randomised trial of Pulmonary vein isolation [PVI] vs PVI with posterior Left Atrial wall isolation [PWI]) was a multicenter trial that randomized patients with PsAF to PVI plus PWI or PVI alone. Follow-up was 12 months. Outcomes were assessed after a 3-month blanking period. RESULTS: A total of 334 patients were included (median age 65.6 years, 23.1% female), 194 (58.1%) had PsAF at first AF diagnosis and 140 (41.9%) had PAF. Patients with PsAF at diagnosis were younger (age 64.0 vs 67.7 years, P = 0.005), had higher rates of heart failure (P < 0.001), and lower left ventricular ejection fraction (54.5%, IQR: 40%-60% vs 60%, IQR: 50%-61%, P = 0.007). AF recurrence occurred in 85 (43.8%) with PsAF at diagnosis and 70 (50%) with PAF at diagnosis. PsAF at diagnosis was not associated with risk of recurrence on univariable (HR: 0.802; 95% CI: 0.585-1.101; P = 0.173) or multivariable analysis (HR: 0.922; 95% CI: 0.647-1.312; P = 0.650). Median AF burden was 0% in both groups (P = 0.125). There was no difference in left atrial size (P = 0.337) or bipolar voltage (P = 0.579) between the groups. CONCLUSIONS: In the CAPLA cohort of patients, pattern of AF at first diagnosis did not influence post-ablation rate of AF recurrence or AF burden. (Catheter Ablation for persistent atrial fibrillation: A Multicentre randomised trial of Pulmonary vein isolation [PVI] vs PVI with posterior Left Atrial wall isolation [PWI]; ACTRN12616001436460).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, The Alfred Hospital, Melbourne, Australia; The Baker Heart and Diabetes Research Institute, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia.
- Department of Cardiology, The Alfred Hospital, Melbourne, Australia; The Baker Heart and Diabetes Research Institute, Melbourne, Australia; Monash School of Medicine, Monash University, Melbourne, Australia.
- Department of Cardiology, The Alfred Hospital, Melbourne, Australia; The Baker Heart and Diabetes Research Institute, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia; Departme…
- Department of Cardiology, The Alfred Hospital, Melbourne, Australia; The Baker Heart and Diabetes Research Institute, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia; Monash S…
- Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia.
- Department of Medicine, University of Melbourne, Melbourne, Australia; Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia.
Zitieren
APA
Crowley, R., Chieng, D., Segan, L., William, J., Sugumar, H., Prabhu, S., Voskoboinik, A., Ling, L. H., Morton, J. B., Lee, G., McLellan, A. J., Wong, M., Pathak, R. K., Sterns, L., Ginks, M., Sanders, P., Kistler, P. M., & Kalman, J. M. (2025). Persistent Atrial Fibrillation Phenotypes and Ablation Outcomes. JACC: Clinical Electrophysiology, 11(1), 10-18. https://doi.org/10.1016/j.jacep.2024.09.018
Vancouver
Crowley R, Chieng D, Segan L, William J, Sugumar H, Prabhu S, et al. Persistent Atrial Fibrillation Phenotypes and Ablation Outcomes. JACC: Clinical Electrophysiology. 2025;11(1):10-18. doi:10.1016/j.jacep.2024.09.018
BibTeX
@article{Crowley2025,
author = {Crowley, Rose and Chieng, David and Segan, Louise and William, Jeremy and Sugumar, Hariharan and Prabhu, Sandeep and Voskoboinik, Aleksandr and Ling, Liang-Han and Morton, Joseph B and Lee, Geoffrey and McLellan, Alex J and Wong, Michael and Pathak, Rajeev K and Sterns, Laurence and Ginks, Matthew and Sanders, Prashanthan and Kistler, Peter M and Kalman, Jonathan M},
title = {Persistent Atrial Fibrillation Phenotypes and Ablation Outcomes},
journal = {JACC: Clinical Electrophysiology},
year = {2025},
volume = {11},
number = {1},
pages = {10--18},
doi = {10.1016/j.jacep.2024.09.018}
}
EUVIMED